These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27600159)

  • 1. Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report.
    Marsili M; Marzetti V; Lucantoni M; Lapergola G; Gattorno M; Chiarelli F; Breda L
    Ital J Pediatr; 2016 Sep; 42(1):81. PubMed ID: 27600159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behçet's disease presenting as a peripheral vestibulopathy.
    White AS; Taylor RL; McNeill C; Garsia R; Welgampola MS
    J Clin Neurosci; 2014 Jun; 21(6):1060-3. PubMed ID: 24559656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with adalimumab for autoimmune sensorineural hearing loss in a patient with Behçet's disease.
    Utsunomiya A; Watanabe T; Shizuki K; Jodo S
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):164-165. PubMed ID: 31376253
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune inner ear disease (AIED): A diagnostic challenge.
    Ciorba A; Corazzi V; Bianchini C; Aimoni C; Pelucchi S; Skarżyński PH; Hatzopoulos S
    Int J Immunopathol Pharmacol; 2018; 32():2058738418808680. PubMed ID: 30376736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab in the treatment of pediatric Behçet's disease: case-based review.
    Poddighe D; Mukusheva Z; Dauyey K; Assylbekova M
    Rheumatol Int; 2019 Jun; 39(6):1107-1112. PubMed ID: 30976833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease.
    De Cassan C; De Vroey B; Dussault C; Hachulla E; Buche S; Colombel JF
    J Crohns Colitis; 2011 Aug; 5(4):364-8. PubMed ID: 21683309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sudden deafness and Behçet's disease].
    Berrettini S; Bruschini P; Sellari Franceschini S; Mita L; Olivieri I; Gemignani G
    Acta Otorhinolaryngol Belg; 1989; 43(3):221-9. PubMed ID: 2618648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensorineural hearing loss and ulcerative colitis.
    Kumar BN; Walsh RM; Wilson PS; Carlin WV
    J Laryngol Otol; 1997 Mar; 111(3):277-8. PubMed ID: 9156068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Otorhinolaryngological manifestations in patients with Behçet disease].
    Morales-Angulo C; Vergara Pastrana S; Obeso-Agüera S; Acle L; González-Gay MÁ
    Acta Otorrinolaringol Esp; 2014; 65(1):15-21. PubMed ID: 24094428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report.
    Lee SW; Lee SY; Kim KN; Jung JK; Chung WT
    Clin Rheumatol; 2010 Jan; 29(1):91-3. PubMed ID: 19816754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute bilateral sensorineural hearing loss caused by immuno-mediated inner ear disease].
    Abbate A; Viaggio MB; Piras D; López L; Hubscher O; Nogués M
    Medicina (B Aires); 2001; 61(6):860-2. PubMed ID: 11808429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation and treatment of immune-mediated inner ear disease.
    Welling DB
    Ear Nose Throat J; 1996 May; 75(5):301-5. PubMed ID: 8935529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant laryngeal destruction in a northern European cohort of Behçet's disease patients.
    Fitzgerald CW; Adeeb F; Timon CV; Shine NP; Fraser AD; Hughes JP
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S123-8. PubMed ID: 26487319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audiovestibular Symptoms in Systemic Autoimmune Diseases.
    Ralli M; D'Aguanno V; Di Stadio A; De Virgilio A; Croce A; Longo L; Greco A; de Vincentiis M
    J Immunol Res; 2018; 2018():5798103. PubMed ID: 30211232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-Behçet disease presenting with acute psychosis in an adolescent.
    Patel P; Steinschneider M; Boneparth A; Lantos G
    J Child Neurol; 2014 Sep; 29(9):NP86-91. PubMed ID: 24092890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurologic appearence of Behçet disease in 14-year old boy treated with adalimumab with good result].
    Iwańczak B; Reich A; Kofla-Dłubacz A; Kazanowska B; Ruczka M
    Pol Merkur Lekarski; 2016 Feb; 40(236):110-2. PubMed ID: 27000816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E; Leccese P; Olivieri I; Latanza L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune inner ear disease.
    Ruckenstein MJ
    Curr Opin Otolaryngol Head Neck Surg; 2004 Oct; 12(5):426-30. PubMed ID: 15377956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated inner ear disease.
    Bovo R; Aimoni C; Martini A
    Acta Otolaryngol; 2006 Oct; 126(10):1012-21. PubMed ID: 16923703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.